d1480f47eaefcb26436f4818ea85befb187f1958
gperez2
  Mon Feb 24 09:17:11 2025 -0800
Announcing the release of the enGenome VarChat track, refs #35081

diff --git src/hg/htdocs/goldenPath/newsarch.html src/hg/htdocs/goldenPath/newsarch.html
index 0eb433811bf..93900cc6f20 100755
--- src/hg/htdocs/goldenPath/newsarch.html
+++ src/hg/htdocs/goldenPath/newsarch.html
@@ -51,30 +51,75 @@
 </div>
 
 <p>You can sign-up to get these announcements via our 
 <a target=_blank href="https://groups.google.com/a/soe.ucsc.edu/g/genome-announce?hl=en">Genome-announce</a>
 email list. We send around one short announcement email every two weeks.</p>
 
 <p>Smaller software changes are not announced here.  A summary of the three-weekly release changes can be 
 found <a target=_blank href="https://genecats.gi.ucsc.edu/builds/versions.html">here</a>. 
 For the full list of our daily code changes head to our <a
 href="https://github.com/ucscGenomeBrowser/kent/commits/master"
 target=_blank>GitHub page</a>. Lastly, see our <a href="credits.html" target="_blank">
 credits page</a> for acknowledgments of the data we host.</p>
 
 <!-- ============= 2025 archived news ============= -->
 <a name="2025"></a>
+
+<a name="022425"></a>
+<h2>Feb. 24, 2025 &nbsp;&nbsp; enGenome VarChat track for human (hg38 and hg19)</h2>
+<p>
+We are happy to announce the release of the enGenome VarChat track for the
+<a target="_blank" href="/cgi-bin/hgTrackUi?db=hg38&g=varChat&position=default" >hg38/GRCh38</a>
+and <a target="_blank"
+href="/cgi-bin/hgTrackUi?db=hg19&g=varChat&position=default">hg19/GRCh37</a> human assemblies,
+available in the Variants in Papers superTrack.
+<a target="_blank" href="https://varchat.engenome.com/">VarChat</a> is an open platform that
+leverages the power of generative artificial intelligence to support the genomic variant
+interpretation process by searching the available scientific literature for each variant and
+condensing it into a brief yet informative text.
+</p>
+
+<p>
+The track shows how many papers the variant was observed in, its gene, its HGVS nomenclature, and
+dbSNP rsID. Variants are color-coded based on the level of literature support, as shown in the
+table below:</p>
+<table>
+  <thead>
+    <tr>
+      <th style="border-bottom: 2px solid #6678B1;">Color</th>
+      <th style="border-bottom: 2px solid #6678B1;">Level of literature support</th>
+    </tr>
+  </thead>
+  <tbody>
+    <tr>
+      <td style="background-color: #012840; width: 50px;"></td>
+      <td align="left">High: at least 25 papers mention the variant</td>
+    </tr>
+    <tr>
+      <td style="background-color: #03738C; width: 50px;"></td>
+      <td align="left">Medium: between 10 and 24 papers mention the variant</td>
+    </tr>
+    <tr>
+      <td style="background-color: #96D2D9; width: 50px;"></td>
+      <td align="left">Low: less than 10 papers mention the variant</td>
+    </tr>
+  </tbody>
+</table>
+<p>
+We would like to thank VarChat for providing the data to UCSC. We would also like to thank Lou
+Nassar, Max Haeussler, and Gerardo Perez for their efforts on this release.</p>
+
 <a name="021425"></a>
 <h2>Feb. 14, 2025 &nbsp;&nbsp; CIViC track for hg19 and hg38 is now available</h2>
 <p>
 We are excited to announce the release of the CIViC track for <a target="_blank"
 href="/cgi-bin/hgTrackUi?db=hg19&g=civic&position=default">hg19/GRCh37</a> and
 <a href="/cgi-bin/hgTrackUi?db=hg38&g=civic&position=default" target="_blank">hg38/GRCh38</a>.
 The <a target="_blank" href="https://civicdb.org/welcome">
 Clinical Interpretation of Variants in Cancer</a> (CIViC) is an online database of clinically
 relevant variant interpretations from expert- and crowd-sourced peer-reviewed literature, clinical
 trials, and some conference abstracts. The details page for a feature will list diseases and
 therapies that have been associated with a genomic variant. Visiting the CIViC page for a variant
 will allow browsing the Molecular Profiles associated with that variant, and in turn each Molecular
 Profile shows the Clinical Evidence and Assertions for various diseases and therapies.
 </p>